Navigation Links
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
Date:6/28/2009

pany and is based in S. Mamede do Coronado, Portugal.

It is the partner of choice for many companies, having a strong presence in the Iberian peninsula as well as in over 10 countries in Latin America and in around 20 French or Portuguese speaking African countries.

BIAL is strongly committed to therapeutic innovation investing approximately 20% of its turnover in research and development every year. Key research areas for BIAL are the central nervous system, the cardiovascular system and allergology. BIAL currently has several other innovative programs under development, which the company expects to bring to the market within the next years, thereby strengthening its position throughout Europe.

Further information about BIAL can be found at http://www.bial.com

References:

1. Elger C, Halász P, Moreira J et al. Long-term add-on treatment of partial epilepsy with eslicarbazepine acetate. Abstract presented at the 28th International Epilepsy Congress, Budapest, Hungary, 28 June 2009 - 2 July 2009.

2. Brodie MJ. Management strategies for refractory localization-related seizures. Epilepsia 2001; 42(Suppl 3):27-30.

3. Halász P, Elger C, Ben-Menachem E et al. Efficacy and safety of eslicarbazepine acetate as add-on treatment to carbamazepine in patients with partial-onset seizures. Abstract presented at the 28th International Epilepsy Congress, Budapest, Hungary, 28 June 2009 - 2 July 2009.

4. Gama H, Elger C, Halász P et al. Time of occurence of adverse events in relation to start of treatment with eslicarbazepine acetate as add-on treatment in patients with partial-onset seizures. Abstract presented at the 28th International Epilepsy Congress, Budapest, Hungary, 28 June 2009 - 2 July 2009.

5. Elger C, French J, Halasz P. et al. Evaluation of Eslicarbazepine Acetate as Add-On T
'/>"/>

SOURCE BIAL
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
2. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
3. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
4. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
5. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
6. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
10. Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
11. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Newswire/ -- Chimerix, Inc., a biopharmaceutical c...eutics to address life-threatening diseases, prese...ead antiviral compound, CMX001, to the World Healt...y Initiative (GHSI). CMX001 is a broad-spectrum a...f smallpox, as well as other serious viral infecti...
(Date:11/6/2009)...- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (...harmaceutical company developing human vaccines fo... Virus) and other infectious agents, today announc...ovided an operational update. ,, Robert McNally...mented, "We are pleased with our progress during t...
(Date:11/6/2009)...- Caraco Pharmaceutical Laboratories, Ltd. (NYSE A...hthalmic solution, 0.5% following a final approval...r Sun Pharma,s Abbreviated New Drug Application (A...n the first day following patent expiration. This ...t to Acular® Ophthalmic Solution, 0.5%, from ...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 1LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 2Men With Angina Do Worse Than Women 53921 1Men With Angina Do Worse Than Women 53921 2Men With Angina Do Worse Than Women 53921 3Watson Pharmaceuticals and Arrow Group Receive FTC Second Request 53919 1Watson Pharmaceuticals and Arrow Group Receive FTC Second Request 53919 2
..., June 1 Physicians at the Karmanos Cancer,Instit..., Risk of Second,Lung Cancer in Patients with Prev...llance, Epidemiology, and End Result (SEER) Regist...nual Meeting in Chicago, IL., ( http://www.newsco...ELO ,GO), Karmanos, Praveen Sivakumaran, M.D., al...
... 2 Data To Be Presented Along With Updated Phase 1...O Annual Meeting -, SOUTH SAN FRANCISCO, Calif. a...rd Pharmaceuticals, Inc. (Nasdaq: PARD ), a bioph...nounced positive preliminary results,from its ongo...with,metastatic colorectal cancer (CRC) and update...
Other Medicine Technology:Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women 2Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 2Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 3Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 4Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 5
(Date:11/6/2009)...n, VA)--Three leading scientific organizations spe... a letter to President Obama today expressing thei...e concerning the use of personal protective equipm...ted or confirmed cases of 2009 H1N1 influenza. T...(SHEA), the Infectious Diseases Society of America...
(Date:11/6/2009)...increase, so does the need to exert more pressure ..., Nov. 6 (HealthDay News) -- Hormonal fluctuations..., a new study finds. , Many professional singers ...n,t been known whether this was because of hormone... as the baby grows. , In this study, researchers f...
(Date:11/6/2009)...imitations seem to wane as years go by, researcher...-- New research suggests that people with multiple...developing the disease are more likely to suffer f...rs with the condition. , The findings, published N...sease who relapse within five years of developing ...
(Date:11/6/2009)...million doses now available, with 8 million more d...y News) -- Although the total doses of H1N1 swine ...s 38 million -- 11 million more than a week ago --... able to get one, U.S. health officials acknowledg...percent of children who tried to get vaccinated co...
(Date:11/6/2009)... WAVonline - the Value-Added Distrib...Rider® Product Lines , ...-added distributor of wireless, security, RFID, Vo...ed that it has partnered with Vecima Networks Inc....ting broadband access to cable, wireless and telep...
Breaking Medicine News(10 mins):Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News:Early Relapse of MS May Mean Fewer Issues Later 2Health News:Most Who Want Swine Flu Shot Can't Get It 2Health News:Most Who Want Swine Flu Shot Can't Get It 3Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3
...21 Before your kids are out the schoolroom door a...take a few preventive steps to help protect their ... sure children eat nutritious meals, exercise, sta...ch shows that typical summer activities can trigge...
... for plastic surgery to boost confidence, whereas ...y - 50% of men would change nothing about their ap...liposuction are on the rise , , MANCHESTER, Engla...rviewed by GFK NOP on behalf of Transform Cosmetic...
...First Company to Surpass $100 Million Contribution...ther Disabilities , , CHICAGO, May 21 Safeway (...after raising a record $10.2 million for the organ...ontributions. The national nonprofit recently desi...
... The Oro Organization, LLC, an online lead... with Medical Hair Restoration. , ...The Oro Organization, LLC, an online lead generati...wanted to partner with one of the industry leaders...
... New York Manhattan based personal injury ...rights of bicyclists hit by motor vehicles. , ... -- As subway fares and the cost of gas rise , mor...id Perecman, a leading New York personal injury l...
... Hispanic style cheese known as Queso Fresco or ...fighting obesity and other related health problems...ng dairy foods while consuming a low-calorie diet ...ommended daily intakes of calcium in dairy product...
Other Medicine News:Health News:Protect Your Kids' Hearts: Summer Activity Can Trigger Genetic Disorder, Say Results for Life, Sudden Cardiac Arrest Association 2Health News:Protect Your Kids' Hearts: Summer Activity Can Trigger Genetic Disorder, Say Results for Life, Sudden Cardiac Arrest Association 3Health News:Transform, the Largest Plastic Surgery Clinic, States That Men Are More Vain Than Women 2Health News:Transform, the Largest Plastic Surgery Clinic, States That Men Are More Vain Than Women 3Health News:Safeway Earns Easter Seals' All-Time Top Corporate Partner Designation 2Health News:Safeway Earns Easter Seals' All-Time Top Corporate Partner Designation 3Health News:Safeway Earns Easter Seals' All-Time Top Corporate Partner Designation 4Health News:The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairReplacement.com 2Health News:New York Personal Injury Lawyer Seeks to Protect Bicyclists From Harm 2Health News:Hispanic Cheese May Prevent Obesity 2
...full interchangeability between femoral and tibial...molded tibial component with a durable cobalt chro....,The AGC® Knee is indicated for use in total...ized options are required. Unique Cam-and-Groove P...
...holmium laser combines excellent cutting, ablation... bloodless procedures. It is also extremely effect... of all compositions, making it an ideal multipurp...smitted through flexible fibers, it is especially ...
Turnstile Casting Stand™
CEMEX Fast Set
Medicine Products: